An estrogen-receptor medicine for specified previously treated hormone-sensitive breast cancers.
Profile scope: Elacestrant. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Body discomfort, fatigue, digestive symptoms, or hot flushes may occur.
Serious risks and warning signs
Jaundice, dark urine, lower-abdominal symptoms, confusion, or marked fatigue requires prompt oncology assessment. Review the full blood-test and interaction plan; do not assume all symptoms are ordinary endocrine effects.
A question for your healthcare team
Which laboratory checks are needed, and which liver or neurological symptoms require immediate contact?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.